Publications by authors named "Maria Polyzoi"

Claim this Profile
C
Cost-Effectiveness Analysis of Adjuvant Olaparib Versus Watch and Wait in the Treatment of Germline BRCA1/2-Mutated, High-Risk, HER2-Negative Early Breast Cancer in Sweden.
Maria Polyzoi, Mattias Ekman, Anja Reithmeier, Johanna Jacob, Emma Karlsson

Pharmacoecon Open· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of nivolumab plus ipilimumab plus two cycles of platinum-doublet chemotherapy versus platinum-doublet chemotherapy alone for first-line treatment of stage IV or recurrent non-small cell lung cancer in the United States.
Maria Polyzoi, Hera Sandhu, Johan Maervoet, Yong Yuan, Mohammad A Chaudhary

J Med Econ· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget impact analysis of demineralized bone matrix in combination with autograft in lumbar spinal fusion procedures for the treatment of lumbar degenerative disc disease in Spain.
Kirk Geale, María Álvarez, Maria Polyzoi, Xavier Màlaga, Cristina Pineda

J Med Econ· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated prevalence and incidence of diagnosed ADHD and health care utilization in adults in Sweden - a longitudinal population-based register study.
Maria Polyzoi, Ewa Ahnemark, Emma Medin, Ylva Ginsberg

Neuropsychiatr Dis Treat· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knowledge and Attitudes towards Antibiotic Use and Resistance - A Latent Class Analysis of a Swedish Population-Based Sample.
Martina Vallin, Maria Polyzoi, Gaetano Marrone, Senia Rosales-Klintz, Karin Tegmark Wisell

PLoS One· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis